NMRA icon

Neumora Therapeutics
NMRA

Upgrade to unlock
Buy
Hold
Sell

4 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
Avg. target
$8
252% upside
High target

4 analyst ratings

positive
1  neutral
25%
negative
Analyst & Firm Rating Price Target Upside
Downside 		Date
RBC Capital
RBC Capital
Brian Abrahams
100% 1-yr NMRA win rate
1 Dec ‘25 2 days ago
Stifel
Stifel
Paul Matteis
17 Nov ‘25 16 days ago
Needham
Needham
Ami Fadia
20% 1-yr NMRA win rate
28 Oct ‘25 1 month ago
Guggenheim
Guggenheim
Yatin Suneja
0% 1-yr NMRA win rate
27 Oct ‘25 1 month ago
JP Morgan
JP Morgan
Tessa Romero
0% 1-yr NMRA win rate
16 Sep ‘25 2 months ago